Overview

Omega 3 Supplements Market is poised to register a CAGR of 8.6% during the forecast period 2022 to 2028.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Omega 3 Supplements Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Omega 3 Supplements Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Omega 3 Supplements Market:
• Nordic Naturals, Inc.
• NutriGold Inc.
• Reckitt Benckiser Group plc
• Pharma Nord B.V
• i-Health, Inc.
• Aker BioMarine AS
• Luhua Biomarine (Shandong) Co., Ltd.
• Pharmavite LLC
• KD Pharma Group
• NOW Foods
• GlaxoSmithKline plc
• Natrol LLC
• Carlson Laboratories
• OmegaBrite
• Optimum Nutrition, Inc.
• VAYA Pharma
• Vital Choice Wild Seafood & Organics, SPC
• Bionova
• The Nature's Bounty Co.
• Arkopharma
(Note: The list of the major players will be updated with the latest market scenario and trends)

Omega 3 Supplements Market Segmentation:
By Source
• Fish Oil
• Krill Oil
• Algae Oil
• Others

By Form
• Tablets
• Capsules
• Soft gels
• Others

By Functionality
• Cardiovascular Health
• Brain, Nervous System & Mental Health
• Eye Diseases
• Diabetes
• Others

By End User
• Adults
• Geriatric
• Pregnant Women
• Children
• Infants

By Distribution Channel
• OTC
 o Supermarkets/ Hypermarkets/Food Stores
 o Drug Stores & Pharmacies
 o Online Retailers
 o Others
• Prescribed

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Omega 3 Supplements Market By Source, By Form, By Functionality, By End User, By Distribution Channel and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1 Objectives of the Study 
   1.2 Market Definition 
   1.3 Market Scope 
       1.3.1 Years Considered for the Study
       1.3.2 Market Covered
   1.4 Currency 
   1.5 Limitations 
   1.6 Stakeholders 

 2. Research Methodology 
    2.1 Research Data 
        2.1.1 Secondary Data
              2.1.1.1 Key Data from Secondary Sources
        2.1.2 Primary Data
              2.1.2.1 Key Data from Primary Sources
    2.2 Market Size Estimation 
    2.3 Market Breakdown and Data Triangulation 
    2.4 Assumptions for the Study  

3. Executive Summary
   3.1 Market Outlook
   3.2 Segment Outlook
   3.3 Competitive Insights

4. Global Omega 3 Supplements Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Omega 3 Supplements Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Omega 3 Supplements Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Global Omega 3 Supplements Market, By Source Historical Analysis and Forecast 2022-2028 (USD Million)
   7.1. Fish Oil
   7.2. Krill Oil
   7.3. Algae Oil
   7.4. Others
 
8. Global Omega 3 Supplements Market, By Form Historical Analysis and Forecast 2022-2028 (USD Million)
   8.1. Tablets
   8.2. Capsules
   8.3. Soft gels
   8.4. Others

9. Global Omega 3 Supplements Market, By Functionality Historical Analysis and Forecast 2022-2028 (USD Million)
   9.1. Cardiovascular Health
   9.2. Brain, Nervous System & Mental Health
   9.3. Eye Diseases
   9.4. Diabetes
   9.5. Others

10. Global Omega 3 Supplements Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
   10.1. Adults
   10.2. Geriatric
   10.3. Pregnant Women
   10.4. Children
   10.5. Infants

11. Global Omega 3 Supplements Market, By Distribution Channel Historical Analysis and Forecast 2022-2028 (USD Million)
   11.1. OTC
         11.1.1. Supermarkets/ Hypermarkets/Food Stores
         11.1.2. Drug Stores & Pharmacies
         11.1.3. Online Retailers
         11.1.4. Others
   11.2. Prescribed

12. North America Omega 3 Supplements Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   12.1. Introduction
   12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
        12.2.1. U.S.A
        12.2.2. Canada
        12.2.3. Mexico
   12.3. Market Size (USD Million) Forecast for North America 2022-2028

13. Latin America Omega 3 Supplements Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. Brazil
          13.2.2. Venezuela
          13.2.3. Argentina
          13.2.4. Rest of Latin America
    13.3. Market Size (USD Million) Forecast for Latin America 2022-2028

14. Europe Omega 3 Supplements Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. Germany
          14.2.2. U.K         
          14.2.3. France
          14.2.4. Italy
          14.2.5. Spain
          14.2.6. Russia
          14.2.7. Poland
          14.2.8. Rest of Europe
    14.3. Market Size (USD Million) Forecast for Europe 2022-2028

15. Asia Pacific Omega 3 Supplements Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    15.1. Introduction
    15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          15.2.1. Japan
          15.2.2. China
          15.2.3. India
          15.2.4. Australia and New Zealand
          15.2.5. ASEAN
          15.2.6. Rest of Asia Pacific
    15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

16. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    16.1. Introduction
    16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          16.2.1. GCC
          16.2.2. Israel
          16.2.3. South Africa
          16.2.4. Rest of MEA
    16.3. Market Size (USD Million) Forecast for MEA 2022-2028

17. Market Share Analysis and Competitive Landscape   
    17.1. Global Landscape - Key Players, Revenue and Presence
    17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    17.3. Global Emerging Companies
    17.4. North America - Market Share Analysis and Key Regional Players
    17.5. Europe - Market Share Analysis and Key Regional Players
    17.6. Asia Pacific - Market Share Analysis and Key Regional Players
    17.7. Global Key Player - Growth Matrix

18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    18.1. Nordic Naturals, Inc.
          18.1.1. Company Overview
          18.1.2. Product Portfolio
          18.1.3. SWOT Analysis
          18.1.4. Financial Overview
          18.1.5. Strategic Overview
    18.2. NutriGold Inc.
          18.2.1. Company Overview
          18.2.2. Product Portfolio
          18.2.3. SWOT Analysis
          18.2.4. Financial Overview
          18.2.5. Strategic Overview 
    18.3. Reckitt Benckiser Group plc
          18.3.1. Company Overview
          18.3.2. Product Portfolio
          18.3.3. SWOT Analysis
          18.3.4. Financial Overview
          18.3.5. Strategic Overview
    18.4. Pharma Nord B.V
          18.4.1. Company Overview
          18.4.2. Product Portfolio
          18.4.3. SWOT Analysis
          18.4.4. Financial Overview
          18.4.5. Strategic Overview
    18.5. i-Health, Inc.
          18.5.1. Company Overview
          18.5.2. Product Portfolio
          18.5.3. SWOT Analysis
          18.5.4. Financial Overview
          18.5.5. Strategic Overview          
    18.6. Aker BioMarine AS
          18.6.1. Company Overview
          18.6.2. Product Portfolio
          18.6.3. SWOT Analysis
          18.6.4. Financial Overview
          18.6.5. Strategic Overview      
    18.7. Luhua Biomarine (Shandong) Co., Ltd.
          18.7.1. Company Overview
          18.7.2. Product Portfolio
          18.7.3. SWOT Analysis
          18.7.4. Financial Overview
          18.7.5. Strategic Overview
    18.8. Pharmavite LLC
          18.8.1. Company Overview
          18.8.2. Product Portfolio
          18.8.3. SWOT Analysis
          18.8.4. Financial Overview
          18.8.5. Strategic Overview 
    18.9. KD Pharma Group
          18.9.1. Company Overview
          18.9.2. Product Portfolio
          18.9.3. SWOT Analysis
          18.9.4. Financial Overview
          18.9.5. Strategic Overview
    18.10. NOW Foods
          18.10.1. Company Overview
          18.10.2. Product Portfolio
          18.10.3. SWOT Analysis
          18.10.4. Financial Overview
          18.10.5. Strategic Overview
    18.11. GlaxoSmithKline plc
          18.11.1. Company Overview
          18.11.2. Product Portfolio
          18.11.3. SWOT Analysis
          18.11.4. Financial Overview
          18.11.5. Strategic Overview
    18.12. Natrol LLC
          18.12.1. Company Overview
          18.12.2. Product Portfolio
          18.12.3. SWOT Analysis
          18.12.4. Financial Overview
          18.12.5. Strategic Overview 
    18.13. Carlson Laboratories
          18.13.1. Company Overview
          18.13.2. Product Portfolio
          18.13.3. SWOT Analysis
          18.13.4. Financial Overview
          18.13.5. Strategic Overview
    18.14. OmegaBrite
          18.14.1. Company Overview
          18.14.2. Product Portfolio
          18.14.3. SWOT Analysis
          18.14.4. Financial Overview
          18.14.5. Strategic Overview
    18.15. Optimum Nutrition, Inc.
          18.15.1. Company Overview
          18.15.2. Product Portfolio
          18.15.3. SWOT Analysis
          18.15.4. Financial Overview
          18.15.5. Strategic Overview          
    18.16. VAYA Pharma
          18.16.1. Company Overview
          18.16.2. Product Portfolio
          18.16.3. SWOT Analysis
          18.16.4. Financial Overview
          18.16.5. Strategic Overview      
    18.17. Vital Choice Wild Seafood & Organics, SPC
          18.17.1. Company Overview
          18.17.2. Product Portfolio
          18.17.3. SWOT Analysis
          18.17.4. Financial Overview
          18.17.5. Strategic Overview
    18.18. Bionova
          18.18.1. Company Overview
          18.18.2. Product Portfolio
          18.18.3. SWOT Analysis
          18.18.4. Financial Overview
          18.18.5. Strategic Overview 
    18.19. The Nature's Bounty Co.
          18.19.1. Company Overview
          18.19.2. Product Portfolio
          18.19.3. SWOT Analysis
          18.19.4. Financial Overview
          18.19.5. Strategic Overview
    18.20. Arkopharma
          18.20.1. Company Overview
          18.20.2. Product Portfolio
          18.20.3. SWOT Analysis
          18.20.4. Financial Overview
          18.20.5. Strategic Overview        

19. Pre and Post COVID-19 Impact
    19.1. Positive influence on the healthcare industry
    19.2. The financial disruption of the manufacturing sector
    19.3. Impact of COVID-19 on emerging companies
    19.4. Significant mandates in the healthcare regulations initiated by administrations
    19.5. The overall economic slowdown of the developing and developed nations

20. FutureWise SME Key Takeaway Points for Client

Tables

Figures